Our sibling site, Drug Delivery Business News, reported today that the medtech giant received FDA approval for its Simplera continuous glucose monitor (CGM).
Simplera, the company’s first disposable, all-in-one CGM, comes in at half the size of previous Medtronic CGMs. Its discreet design simplifies the insertion and wear process and eliminates the need for overtape.
The Medtronic Simplera platform includes the Simplera CGM for use with the InPen smart insulin pen and Simplera Sync for integration with the MiniMed 780G automated insulin delivery system.
Get the full story at our sister site, Drug Delivery Business News.
